Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer

BACKGROUND: Bladder cancer is the most common malignancy of the urinary system. However, patient prognosis and treatment outcomes in bladder cancer are difficult to predict owing to high tumor heterogeneity. Given that abnormal glutamine metabolism has been identified as a key factor driving the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yan, Xia, Zhixiu, Sun, Xiaoyu, Wei, Baojun, Fu, Yang, Shi, Du, Zhu, Yuyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995899/
https://www.ncbi.nlm.nih.gov/pubmed/36911676
http://dx.doi.org/10.3389/fimmu.2023.1111319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995899/
https://www.ncbi.nlm.nih.gov/pubmed/36911676
http://dx.doi.org/10.3389/fimmu.2023.1111319

Ejemplares similares